A semaglutide therapy launches in Brazil with BD's injection pen
BD (Becton, Dickinson and Company) and EMS, a leading Brazilian pharmaceutical company, have collaborated to launch an EMS semaglutide therapy in Brazil using the BD Vystra™ Injection Pen platform. This partnership aims to enhance access to GLP-1 treatments for chronic metabolic diseases like obesity …